Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
October 1, 1998Journal of Antimicrobial Chemotherapy

In-vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis

View Full Paper
Ask AI
Bookmark
Share

Authors

CLCornelia Lass‐FlörlStatens Serum InstitutGKG KoflerUniversität InnsbruckGKGabriele KropshoferInnsbruck Medical University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Lass‐Flörl et al. (1998) studied this question.

synapsesocial.com/papers/6a823896a8461dff0846c3e1https://doi.org/10.1093/jac/42.4.497
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Comparative and collaborative evaluation of standardization of antifungal susceptibility testing for filamentous fungi1995 · 246 citations
  2. 2Autologous Bone Marrow Transplantation as Compared with Salvage Chemotherapy in Relapses of Chemotherapy-Sensitive Non-Hodgkin's Lymphoma1995 · 2,457 citations
  3. 3Epidemiology and pathogenesis of systemic fungal infections in the immunocompromised host1991 · 128 citations
  4. 4Invasive aspergillosis in immunocompromised patients1994 · 58 citations